Brenner MK - Search Results

1

Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy.

Atilla PA, McKenna MK, Watanabe N, Mamonkin M, Brenner MK, Atilla E. Atilla PA, et al. Among authors: brenner mk. Cytotherapy. 2022 Mar;24(3):282-290. doi: 10.1016/j.jcyt.2021.10.007. Epub 2021 Dec 23. Cytotherapy. 2022. PMID: 34955406 Free PMC article.

2

Selection of chronic lymphocytic leukemia binding peptides.

Takahashi S, Mok H, Parrott MB, Marini FC 3rd, Andreeff M, Brenner MK, Barry MA. Takahashi S, et al. Among authors: brenner mk. Cancer Res. 2003 Sep 1;63(17):5213-7. Cancer Res. 2003. PMID: 14500347

3

An in vivo propagated human acute myeloid leukemia expressing ABCA3.

Norwood K, Wang RY, Hirschmann-Jax C, Andreeff M, Brenner MK, Goodell MA, Wulf GG. Norwood K, et al. Among authors: brenner mk. Leuk Res. 2004 Mar;28(3):295-9. doi: 10.1016/j.leukres.2003.08.006. Leuk Res. 2004. PMID: 14687625

4

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.

Cruz CR, Hanley PJ, Liu H, Torrano V, Lin YF, Arce JA, Gottschalk S, Savoldo B, Dotti G, Louis CU, Leen AM, Gee AP, Rooney CM, Brenner MK, Bollard CM, Heslop HE. Cruz CR, et al. Among authors: brenner mk. Cytotherapy. 2010 Oct;12(6):743-9. doi: 10.3109/14653241003709686. Cytotherapy. 2010. PMID: 20429793 Free PMC article.

5

Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b.

Craddock JA, Lu A, Bear A, Pule M, Brenner MK, Rooney CM, Foster AE. Craddock JA, et al. Among authors: brenner mk. J Immunother. 2010 Oct;33(8):780-8. doi: 10.1097/CJI.0b013e3181ee6675. J Immunother. 2010. PMID: 20842059 Free PMC article.

6

Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia.

Okur FV, Yvon E, Biagi E, Dotti G, Carrum G, Heslop H, Mims MP, Fratantoni JC, Peshwa MV, Li L, Brenner MK. Okur FV, et al. Among authors: brenner mk. Cytotherapy. 2011 Oct;13(9):1128-39. doi: 10.3109/14653249.2011.592523. Epub 2011 Jul 12. Cytotherapy. 2011. PMID: 21745159 Free PMC article.

7

CAR T cells for acute myeloid leukemia: the LeY of the land.

Brenner MK. Brenner MK. Mol Ther. 2013 Nov;21(11):1983-4. doi: 10.1038/mt.2013.234. Mol Ther. 2013. PMID: 24201214 Free PMC article. No abstract available.

8

Engineered T cells for cancer treatment.

Anurathapan U, Leen AM, Brenner MK, Vera JF. Anurathapan U, et al. Among authors: brenner mk. Cytotherapy. 2014 Jun;16(6):713-33. doi: 10.1016/j.jcyt.2013.10.002. Epub 2013 Nov 13. Cytotherapy. 2014. PMID: 24239105 Free PMC article. Review.

9

Design and development of therapies using chimeric antigen receptor-expressing T cells.

Dotti G, Gottschalk S, Savoldo B, Brenner MK. Dotti G, et al. Among authors: brenner mk. Immunol Rev. 2014 Jan;257(1):107-26. doi: 10.1111/imr.12131. Immunol Rev. 2014. PMID: 24329793 Free PMC article. Review.

10

Reversal of tumor immune inhibition using a chimeric cytokine receptor.

Leen AM, Sukumaran S, Watanabe N, Mohammed S, Keirnan J, Yanagisawa R, Anurathapan U, Rendon D, Heslop HE, Rooney CM, Brenner MK, Vera JF. Leen AM, et al. Among authors: brenner mk. Mol Ther. 2014 Jun;22(6):1211-1220. doi: 10.1038/mt.2014.47. Epub 2014 Mar 20. Mol Ther. 2014. PMID: 24732709 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters